-
Most Recent
Search Results
240 results for IIJI
3 Infrastructure Stocks Positioned for Potential Government Spending
See how these infrastructure stocks are set to benefit from the infrastructure boom fueled by government spending.
Is Bank of America Still Broke After Buffett, China Bank Deals?
Yes, the company has raised lots of capital — but while it might be enough to cover Basel III rules, it might not be enough…
Mess or Success: The BlackBerry Guessing Game
BlackBerry has a lot riding on the success of its new smartphones and operating system, but information around its new Z10 has been enveloped in…
Finish Line Inc (FINL) and WashingtonFirst Bankshares Inc (WFBI) Lead 9 Investor Filings
Finish Line Inc is among the 13G and 13D activist investor filings over the past week
AstraZeneca plc (ADR) (AZN) Stock Tanks on Lung Cancer Drug Disappointment
AstraZeneca(AZN) stock was hit hard Thursday after its new lung cancer drug failed to meet a primary endpoint in a Phase III trial.
3 Retail Stocks to Buy Off the Rack
Retail stocks, especially apparel stocks, are having a bad start to the year. But there are still some worth buying, like these three hidden gems.
No Payday In Sight for Alzheimer’s Drug Stocks
At best, the drugs on the market are stopgap measures. They can’t cure the disease.
Should You Buy Canopy Growth (CGC) Stock Before May 30?
While Canopy Growth is in the news thanks to marijuana’s reclassification proposal, CGC stock carries questions ahead of earnings.
Abbott Labs Spinoff Looks Like the Right Move
Shareholders would likely be better served by the company’s prescription drug business standing alone. Here’s why.
GLSI Stock: Why Greenwich LifeSciences Is Up 2,000% Today
GLSI stock is soaring Wednesday after Greenwich LifeSciences shared promising results from its breast cancer immunothrapy.
How U.S. Legal Reforms Could Send This Cannabis Stock Skywards
Tilray would be a major beneficiary of pro-cannabis legal reforms, and TLRY stock has been so beaten-down that the next move should be up.
Sears Bankruptcy Could Be Just Days Away
It looks like we’ll finally be seeing a Sears bankruptcy in the next few days after talk for years about it as the retailer declines.
3 Ways to Invest in Weed BESIDES Marijuana Stocks (GWPH, XXII, MO)
Most marijuana stocks trade on the loosely-regulated OTC markets, but GWPH, XXII and MO are three alternatives to typical weed plays.
AbbVie Inc (ABBV) Is About to Steamroll the Competition
Good news for AbbVie (ABBV) shareholders: The pharmaceutical company just entered the Hepatitis C. market, while reinforcing its position in the psoriasis area. Given ABBV’s…
4 Reasons Celgene Is the Real Deal
Celgene has reached all-time highs in the wake of the firm’s boffo reviews at this week’s JPMorgan Healthcare Conference … and it’s still worth buying.
Amgen Bids for a Return to Favor
Amgen’s (AMGN) third-quarter earnings, budget management and full-year outlook turn positive, boosting the company’s market prospects.
The Legend of Tarzan: First Photos Revealed
The first photos of the 2016 film ‘Legend of Tarzan’ have been revealed, starring Alexander Skarsgard as the title role.
From Test Tube to the Drugstore: How Are Human Clinical Trials Conducted?
How are clinical trials conducted and just what do they accomplish? We take a look at a process lasting years, which determines what drugs go…
Is AstraZeneca a Buy After Pfizer Breakup? 3 Pros, 3 Cons
AZN turned down Pfizer’s offer — a premium of more than 40% for AZN stock — sending shares down more than 10%. But is that…
High Hopes: Could 4/20 Light Up a Cannabis Stock Rally?
April 20 is right around the corner. Could the date mean a cannabis stock rally? Here’s what could happen.
Friday Apple Rumors: iPhone Could Boost China Mobile 3G Use
An analyst says China Mobile needs the iPhone; the iPad’s effect on notebook sales is slowing: and Apple’s App Store spreads to 32 more countries.
10 – 10 of 240 results
